Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 18, 2022 10:15 ET | Source: Psycheceutical Bioscience, Inc.

Psycheceutical Bioscience, Inc. Announces Medical Advisory Board

MIAMI, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for...
October 10, 2022 11:00 ET | Source: ARTIS Ventures

ARTIS Ventures Welcomes Henry Klingenstein to Its Investment Team

San Francisco, Oct. 10, 2022 (GLOBE NEWSWIRE) -- ARTIS Ventures, a leading venture firm pioneering investments in the TechBio space, today announced Henry Klingenstein has joined the investment...
October 05, 2022 12:00 ET | Source: Quantum Genomics

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal products...
October 03, 2022 07:30 ET | Source: Atsena Therapeutics

Atsena Therapeutics Announces Positive Results from Phase I/II Clinical Trial of ATSN-101 for the Treatment of GUCY2D-associated Leber Congenital Amaurosis (LCA1)

ATSN-101 demonstrated clinically meaningful improvements in vision with no drug-related serious adverse events Data presented at the American Academy of Ophthalmology 2022 Annual Meeting DURHAM,...
September 29, 2022 18:34 ET | Source: Rudd Resources

Rudd Resources elevates David Rudd and Jessica Bee to new positions

Chicago, IL, Sept. 29, 2022 (GLOBE NEWSWIRE) -- CHICAGO, Ill. – David C. Rudd and Jessica Bee have been promoted to executive vice president and vice president, respectively, at Rudd Resources, a...
September 27, 2022 07:00 ET | Source: Nuwellis, Inc.

Nuwellis Announces the Activation of New Sites for Its Pivotal REVERSE-HF Trial

MINNEAPOLIS, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the...
September 22, 2022 08:10 ET | Source: Husson University

Author Who Created "Rizzoli & Isles" is Next Husson University Distinguished Business Speaker Series Guest

BANGOR, MAINE, Sept. 22, 2022 (GLOBE NEWSWIRE) -- The seventh installment of Husson University’s Distinguished Business Speaker Series will feature international bestselling author Tess Gerritsen....
September 21, 2022 07:30 ET | Source: Atsena Therapeutics

Atsena Therapeutics Announces Late-Breaker Presentation at the American Academy of Ophthalmology 2022 Annual Meeting

Data from Phase I/II trial of ATSN-101 in patients with GUCY2D-associated Leber congenital amaurosis (LCA1) to be presented DURHAM, N.C., Sept. 21, 2022 (GLOBE NEWSWIRE) -- Atsena Therapeutics, a...
September 19, 2022 10:04 ET | Source: Accreditation Council for Graduate Medical Education

New Clinician Educator Milestones Provide Pathways for Professional Development and Framework for Assessment

Chicago, IL, Sept. 19, 2022 (GLOBE NEWSWIRE) -- The Accreditation Council for Graduate Medical Education (ACGME), in partnership with the Accreditation Council for Continuing Medical Education...
September 15, 2022 16:11 ET | Source: CURE Media Group

CURE Media Group Announces 2022 Lung Cancer Heroes Award Winners

The third-annual awards program will honor three heroes for their outstanding contributions in the field of lung cancer, the deadliest and second most common form of cancer, at a Sept. 23 event during...